Prostate Cancer Chemotherapy: Emerging From the Shadows-Reference-Cited by-同舟云学术

Prostate Cancer Chemotherapy: Emerging From the Shadows

Published:2005-05-20 Issue:15 Volume:23 Page:3302-3303
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Roth Bruce J.¹

Affiliation:

1. Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.11.933

Reference12 articles.

1. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

2. Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

3. Picus J, Schultz M: Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: Preliminary results. Semin Oncol 26:14,1999-18, (suppl 17)

4. Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer

5. Speicher LA, Barone L, Tew KD: Combined antimicrotubular activity of estramustine and Taxol in human prostatic carcinoma cell lines. Cancer Res 52:4433,1992-4440,

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytotoxic triplets plus a biologic: state-of-the-art in maximizing the potential of up-front medical treatment of metastatic colorectal cancer;Expert Opinion on Biological Therapy;2011-01-27

2. Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer;BMC Cancer;2011-01-25

3. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells;Cancer Gene Therapy;2010-05-07

4. Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer;Cancer Chemotherapy and Pharmacology;2009-10-31

5. C/EBPβ regulates metastatic gene expression and confers TNF-α resistance to prostate cancer cells;The Prostate;2009-09-15